NewslettersHuman Immunology NewsNeoantigen Targetability in Progressive Advanced MelanomaBy Bob - August 8, 20230174Researchers investigated the targetability of neoantigens in advanced progessive melanoma and explored the potential for continued T cell-based immunotherapy.[Clinical Cancer Research]Abstract